Arthroscopic Management for Hip Joint Septic Arthritis: A Retrospective Study of 28 Adult Patients With a Minimum 3-Year Follow-Up

Shu Chen , Yaguang Han , Yiqin Zhou , Jiahua Shao , Zheru Ding , Jia Cao , Haobo Li , Lei Zhang , Qirong Qian , Jinhui Peng

Orthopaedic Surgery ›› 2026, Vol. 18 ›› Issue (1) : 101 -112.

PDF
Orthopaedic Surgery ›› 2026, Vol. 18 ›› Issue (1) :101 -112. DOI: 10.1111/os.70227
CLINICAL ARTICLE
Arthroscopic Management for Hip Joint Septic Arthritis: A Retrospective Study of 28 Adult Patients With a Minimum 3-Year Follow-Up
Author information +
History +
PDF

Abstract

Objective: Hip septic arthritis is a relatively rare yet severe cause of acute hip pain, with the potential to rapidly destroy articular cartilage, lead to osteonecrosis, and cause osteomyelitis. This life-threatening infection demands early diagnosis and appropriate treatment. Our study aims to assess the surgical safety and efficacy of arthroscopic management for this condition and to optimize the arthroscopic treatment protocol by customizing surgical interventions based on intraoperative findings and disease stages.

Methods: We conducted a retrospective study of 28 patients (18 females, 10 males; average age of 49 ± 10.5 years) from January 2018 to March 2022. Diagnosis of hip septic arthritis was confirmed via synovial fluid examination, culture, or synovial pathology. Patients underwent arthroscopic joint lavage, synovectomy, and drainage tailored to the intraoperative situation and the Gächter stage. Antibiotics were administered based on drug-sensitivity results or empirically. We recorded and analyzed symptoms, comorbidities, stages, inflammatory marker levels, culture results, antibiotic duration, outcomes, and complications.

Results: The mean time from symptom onset to surgery was 10.2 ± 8.6 (range, 4–45) days. All patients had elevated inflammatory markers. Pre-operative bacterial cultures were positive in 6 cases, and post-operative cultures were positive in 21 cases. Staphylococcus aureus was the most frequently detected pathogen (10 cases), accounting for approximately 47.6% of the positive culture cases. Antibiotic therapy lasted 4–6 weeks. The C-reactive protein normalized on average 43 days after surgery; the erythrocyte sedimentation rate normalized 54 days postoperatively. At final follow-up (mean 42 months), the visual analog scale score decreased from 6.6 ± 1.3 to 1.3 ± 0.2 (p = 0.003), and the modified Harris Hip Score improved from 52 ± 8.1 to 85 ± 8.6 (p = 0.001). Infection was controlled in all patients within 6 months. Two patients (Gächter stage III/IV) had recurrent infections at 8 and 11 months, successfully treated with repeat arthroscopy. Gächter stage III or IV was a significant risk factor for recurrence. Two patients underwent total hip arthroplasty due to secondary osteoarthritis and osteonecrosis. No major complications occurred.

Conclusion: Stage-based arthroscopic lavage, synovectomy, and drainage combined with antibiotics is effective for hip septic arthritis. The optimized procedure offers a safe and effective option, particularly for early-stage (Gächter I–II) disease, while advanced stages (III–IV) require cautious management due to higher recurrence risk.

Keywords

drainage / hip arthroscopy / lavage / septic arthritis / synovectomy

Cite this article

Download citation ▾
Shu Chen, Yaguang Han, Yiqin Zhou, Jiahua Shao, Zheru Ding, Jia Cao, Haobo Li, Lei Zhang, Qirong Qian, Jinhui Peng. Arthroscopic Management for Hip Joint Septic Arthritis: A Retrospective Study of 28 Adult Patients With a Minimum 3-Year Follow-Up. Orthopaedic Surgery, 2026, 18(1): 101-112 DOI:10.1111/os.70227

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

A. S. Hassan, A. Rao, A. M. Manadan, and J. A. Block, “Peripheral Bacterial Septic Arthritis: Review of Diagnosis and Management,” Journal of Clinical Rheumatology 23, no. 8 (2017): 435–442.

[2]

Z. C. Lum, A. K. Shieh, and J. P. Meehan, “Native Adult Hip With Bacterial Septic Arthritis,” JBJS Reviews 6, no. 10 (2018): e2.

[3]

S. McBride, J. Mowbray, W. Caughey, et al., “Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults,” Clinical Infectious Diseases 70, no. 2 (2020): 271–279.

[4]

Y. C. Huang, C. H. Ho, Y. J. Lin, et al., “Site-Specific Mortality in Native Joint Septic Arthritis: A National Population Study,” Rheumatology (Oxford, England) 59, no. 12 (2020): 3826–3833.

[5]

Q. Lu, X. Yang, M. Chen, Z. Mao, and H. Ling, “Comparison of the Results of Medical Approach and Surgical Approach of Septic Arthritis in Native Joints: A Single-Center Retrospective Study,” BMC Musculoskeletal Disorders 25, no. 1 (2024): 1092.

[6]

T. Tan, C. Xu, F. C. Kuo, E. Ghanem, C. Higuera, and J. Parvizi, “Risk Factors for Failure and Optimal Treatment of Total Joint Arthroplasty for Septic Arthritis,” Journal of Arthroplasty 36, no. 3 (2021): 892–896.

[7]

C. J. Mathews, V. C. Weston, A. Jones, M. Field, and G. Coakley, “Bacterial Septic Arthritis in Adults,” Lancet 375, no. 9717 (2010): 846–855.

[8]

J. G. Hunter, J. M. Gross, J. D. Dahl, S. L. Amsdell, and J. T. Gorczyca, “Risk Factors for Failure of a Single Surgical Debridement in Adults With Acute Septic Arthritis,” Journal of Bone and Joint Surgery. American Volume 97, no. 7 (2015): 558–564.

[9]

B. J. Flores-Robles, M. Jimenez Palop, A. A. Sanabria Sanchinel, et al., “Medical Versus Surgical Approach to Initial Treatment in Septic Arthritis: A Single Spanish Center's 8-Year Experience,” Journal of Clinical Rheumatology 25, no. 1 (2019): 4–8.

[10]

C. Mabille, Y. El Samad, C. Joseph, et al., “Medical Versus Surgical Treatment in Native Hip and Knee Septic Arthritis,” Infectious Diseases Now 51, no. 2 (2021): 164–169.

[11]

D. L. Goldenberg, “Septic Arthritis,” Lancet 351, no. 9097 (1998): 197–202.

[12]

I. Nusem and A. McAlister, “Arthroscopic Lavage for the Treatment of Septic Arthritis of the Hip in Children,” Acta Orthopaedica Belgica 78, no. 6 (2012): 730–734.

[13]

A. Nannini, R. Giorgino, L. Bianco Prevot, et al., “Septic Arthritis in the Pediatric Hip Joint: A Systematic Review of Diagnosis, Management, and Outcomes,” Frontiers in Pediatrics 11 (2023): 1311862.

[14]

S. Appelhaus, S. O. Schoenberg, and M. Weis, “Septic Arthritis and Transient Synovitis of the Hip,” Radiologie (Heidelberg) 63, no. 10 (2023): 729–735.

[15]

C. Ravn, J. Neyt, N. Benito, et al., “Guideline for Management of Septic Arthritis in Native Joints (SANJO),” Journal of Bone and Joint Infection 8, no. 1 (2023): 29–37.

[16]

C. M. Blitzer, “Arthroscopic Management of Septic Arthritis of the Hip,” Arthroscopy 9, no. 4 (1993): 414–416.

[17]

S. A. Yeargan,, J. J. Perry,, T. J. Kane,, and A. B. Richardson, “Hematogenous Septic Arthritis of the Adult Hip,” Orthopedics 26, no. 8 (2003): 771–776.

[18]

G. Balato, V. de Matteo, T. Ascione, et al., “Management of Septic Arthritis of the Hip Joint in Adults. A Systematic Review of the Literature,” BMC Musculoskeletal Disorders 22, no. Suppl 2 (2021): 1006.

[19]

A. B. Walinga, T. Stornebrink, K. S. Emanuel, A. J. Kievit, S. J. Janssen, and G. Kerkhoffs, “Failure Rates in Surgical Treatment in Adults With Bacterial Arthritis of a Native Joint: A Systematic Review of 8,586 Native Joints,” Archives of Orthopaedic and Trauma Surgery 143, no. 11 (2023): 6547–6559.

[20]

G. S. Linden, S. E. Lipson, V. Desai, et al., “Injection Drug Use Is Associated With Repeat Irrigation and Debridement in Native Joint Septic Arthritis,” Journal of Orthopaedics 64 (2025): 18–22.

[21]

M. E. Margaretten, J. Kohlwes, D. Moore, and S. Bent, “Does This Adult Patient Have Septic Arthritis?,” JAMA 297, no. 13 (2007): 1478–1488.

[22]

J. Evrard and B. Soudrie, “Primary Arthritis of the Hip in Adults,” International Orthopaedics 17, no. 6 (1993): 367–374.

[23]

L. Sharoff, M. Bowditch, and R. Morgan-Jones, “Management of Septic Arthritis and Prosthetic Joint Infection,” British Journal of Hospital Medicine (London, England) 85, no. 1 (2024): 1–9.

[24]

A. Gachter, “Der Gelenkinfekt,” Informierte Arzt 6 (1985): 35–43.

[25]

Y. K. Lee, K. S. Park, Y. C. Ha, and K. H. Koo, “Arthroscopic Treatment for Acute Septic Arthritis of the Hip Joint in Adults,” Knee Surgery, Sports Traumatology, Arthroscopy 22, no. 4 (2014): 942–945.

[26]

M. Ivey and R. Clark, “Arthroscopic Debridement of the Knee for Septic Arthritis,” Clinical Orthopaedics and Related Research 199 (1985): 201–206.

[27]

M. A. Kelly, “Role of Arthroscopic Debridement in the Arthritic Knee,” Journal of Arthroplasty 21, no. 4 Suppl 1 (2006): 9–10.

[28]

M. Bould, D. Edwards, and R. N. Villar, “Arthroscopic Diagnosis and Treatment of Septic Arthritis of the Hip Joint,” Arthroscopy 9, no. 6 (1993): 707–708.

[29]

A. Kaminski, G. Muhr, and F. Kutscha-Lissberg, “Modified Open Arthroscopy in the Treatment of Septic Arthritis of the Hip,” Ortopedia, Traumatologia, Rehabilitacja 9, no. 6 (2007): 599–603.

[30]

A. Shukla, S. K. Beniwal, and S. Sinha, “Outcome of Arthroscopic Drainage and Debridement With Continuous Suction Irrigation Technique in Acute Septic Arthritis,” Journal of Clinical Orthopaedics and Trauma 5, no. 1 (2014): 1–5.

[31]

J. H. Schroder, D. Kruger, C. Perka, and M. Hufeland, “Arthroscopic Treatment for Primary Septic Arthritis of the Hip in Adults,” Advances in Orthopedics 2016 (2016): 8713037.

RIGHTS & PERMISSIONS

2025 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.

PDF

6

Accesses

0

Citation

Detail

Sections
Recommended

/